RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      SCOPUS KCI등재

      소화성 궤양에 대한 Nizatidine 의 치료 효과 = The Effect of Nizatidine in the Treatment of Popitic Ulcer Disease소화성 궤양에 대한 Nizatidine 의 치료 효과

      한글로보기

      https://www.riss.kr/link?id=A3367465

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

      Nizatidine is new H2-receptor blocker with a thiazole ring. We evaluate the clinical efficacy and safety of the Nizatidine in 30 cases of endoscopically-proven peptic ulcer diseases. Nizatidine was administered 150 mg twice daily for 4 or 8 weeks and then followed by endoscopy. Overall improvement of peptic ulcer diseases by endoscopic evaluation noted in 26 (86.9%) of 30 patients. 7 out of 8 cases (87.5%) of gastric ulcers and 19 out of 22 cases (86.3%) of duodenal ulcers had been healed in 4 or 8 weeks. Clinical symptoms of peptic ulcer diseases had been improved in 29 out of 30 cases (96.7%) after 4 or 8 weeks medication with Nizatidine. No significant clinical side effects and laboratory changes had been noticed during therapy. In conclusion, nizatidine was effective and safe drug for the treatment of peptic ulcer diseases.
      번역하기

      Nizatidine is new H2-receptor blocker with a thiazole ring. We evaluate the clinical efficacy and safety of the Nizatidine in 30 cases of endoscopically-proven peptic ulcer diseases. Nizatidine was administered 150 mg twice daily for 4 or 8 weeks and ...

      Nizatidine is new H2-receptor blocker with a thiazole ring. We evaluate the clinical efficacy and safety of the Nizatidine in 30 cases of endoscopically-proven peptic ulcer diseases. Nizatidine was administered 150 mg twice daily for 4 or 8 weeks and then followed by endoscopy. Overall improvement of peptic ulcer diseases by endoscopic evaluation noted in 26 (86.9%) of 30 patients. 7 out of 8 cases (87.5%) of gastric ulcers and 19 out of 22 cases (86.3%) of duodenal ulcers had been healed in 4 or 8 weeks. Clinical symptoms of peptic ulcer diseases had been improved in 29 out of 30 cases (96.7%) after 4 or 8 weeks medication with Nizatidine. No significant clinical side effects and laboratory changes had been noticed during therapy. In conclusion, nizatidine was effective and safe drug for the treatment of peptic ulcer diseases.

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼